Medical Science Liaison (13-month contrat)
Field-based — Greater Toronto Area
Join Novo Nordisk Canada as a Medical Science Liaison and help translate scientific evidence into real-world improvements in patient care across Ontario, Manitoba and Atlantic Canada.
Your new role
As a Medical Science Liaison (MSL) in the Rare Disease team, you are a vital scientific resource who establishes and maintains collaborative relationships with key external stakeholders, including healthcare professionals and academic institutions. You serve as a bridge between the clinical community and Novo Nordisk, providing expert scientific knowledge to support research, product understanding, and clinical care. The role involves disseminating accurate and relevant information while engaging in scientific discussions that enhance the understanding of our portfolio and its impact on patient care.
Day-to-day your tasks will include:
Your new department
You will join International Operations — our largest operational unit — and be part of the Rare Disease team in Canada. More than 18,000 colleagues in International Operations work to serve millions of patients worldwide, in Canada our team delivers scientific excellence, strategic medical guidance and strong partnerships with the clinical community. This role offers a collaborative environment where your expertise will help advance medical knowledge and improve patient outcomes.
Your skills & qualifications
To succeed in this role, you should:
Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change; we drive it. In a dynamic industry, we strive for excellence without fixating on perfection. We embrace opportunities for development across all areas, from research to sales, to improve patient care.
More information
For more information, visit novonordisk.com,Facebook, Instagram, X, LinkedIn and YouTube.To complete your application, click on "Apply now", attach your CV and follow the instructions.
Deadline
Please apply before December 31st, 2025. (Applications are reviewed on an ongoing basis)
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html